Phivida Holdings Inc (CSE:VIDA) was featured on Baystreet in an article about the company’s warrant conversion.
The article positioned Phivida as a powerful new entrant to the medical cannabis sector which is capturing the imagination of investors. The author writes “few companies have sprinted from the starting gun harder and faster than Vancouver-based Phivida, offering cannabidiol (“CBD”) infused functional foods, beverages and clinical products.“
The article outlined the warrant conversion and how it’s a good news for shareholders. The author stresses that through the warrant conversion they have an opportunity to maintain their pro-rata position at a lower risk level, by converting and holding.
The article further discussed about the effects of the conversion and states that “the effect of this conversion is a company with about $11 million in cash—effectively doubling Phivida’s position in only 24 trading days.”
The article further talks about the company’s future and ongoing practices in favourable words. “Phivida is rapidly developing CBD infused products under three banners: 1. Organics: professional grade, wholesale whole plant hemp oil extracts; 2. Nutrition: iced tea, vitamin juice and shakes; and 3. Enhanced: tinctures and vitamin shots. In the US, Phivida has already secured a distribution agreement in California and a brand licensing agreement in Oregon with an eye on more agreement to come from Washington and Colorado. Internationally, Phivida recently named Namaste as its preferred global online retailer, initially focused on the German and Australian territories. The company also secured a product distribution agreement with Asayake Inc. to sell its cannabidiol products across Japan. At this pace, and with plenty of fuel in the tank, investors can look forward to more agreements from Phivida in the weeks, months, and years to come,” concluded the author.
Click here to read the complete article
Click here to connect with Phivida Holdings Inc (CSE:VIDA) to receive an Investor Presentation.